These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 4048864)

  • 1. The in vitro effect of leucocyte alpha-interferon on human myeloma cells in a semisolid agar culture system.
    Brenning G
    Scand J Haematol; 1985 Aug; 35(2):178-85. PubMed ID: 4048864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between in vitro and in vivo sensitivity to human leucocyte interferon in patients with multiple myeloma.
    Brenning G; Ahre A; Nilsson K
    Scand J Haematol; 1985 Nov; 35(5):543-9. PubMed ID: 4089532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-6 is a cofactor for the growth of myeloid cells from human bone marrow aspirates but does not affect the clonogenicity of myeloma cells in vitro.
    Borinaga AM; Millar BC; Bell JB; Joffe JK; Millar JL; Gooding R; Riches P; McElwain TJ
    Br J Haematol; 1990 Dec; 76(4):476-83. PubMed ID: 2265109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies of interferon as a regulator of hematopoietic cell proliferation.
    Raefsky EL; Platanias LC; Zoumbos NC; Young NS
    J Immunol; 1985 Oct; 135(4):2507-12. PubMed ID: 2411798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitive inhibitory effect of interferon-alpha on M-protein secretion of human myeloma cells.
    Tanaka H; Tanabe O; Iwato K; Asaoku H; Ishikawa H; Nobuyoshi M; Kawano M; Kuramoto A
    Blood; 1989 Oct; 74(5):1718-22. PubMed ID: 2790196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of cloned human leukocyte interferons in the human tumor stem cell assay.
    Salmon SE; Durie BG; Young L; Liu RM; Trown PW; Stebbing N
    J Clin Oncol; 1983 Mar; 1(3):217-25. PubMed ID: 6686847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant interferon-gamma inhibits the in vitro proliferation of human myeloma cells.
    Palumbo A; Battaglio S; Napoli P; Omedè P; Fusaro A; Bruno B; Boccadoro M; Pileri A
    Br J Haematol; 1994 Apr; 86(4):726-32. PubMed ID: 7918064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitivity of Ph 1 + CFU-GM to human recombinant interferon alpha and gamma alone and in combination.
    Visani G; Russo D; Damiani D; Rizzi S; Motta MR; Lemoli RM; Poluzzi C; Fanin R; Zuffa E; Tosi P
    Blut; 1988 Jul; 57(1):41-4. PubMed ID: 3134069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of the antiproliferative properties of recombinant human IFN-alpha 2 and IFN-omega in human bone marrow culture.
    Tiefenthaler M; Geisen F; Schirmer M; Konwalinka G
    J Interferon Cytokine Res; 1997 Jun; 17(6):327-9. PubMed ID: 9197999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review of experience with interferon and drug sensitivity testing of ovarian carcinoma in semisolid agar culture.
    Epstein LB; Marcus SG
    Cancer Chemother Pharmacol; 1981; 6(3):273-7. PubMed ID: 6172214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferons in the treatment of multiple myeloma.
    Cooper MR; Welander CE
    Cancer; 1987 Feb; 59(3 Suppl):594-600. PubMed ID: 3802025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential sensitivity of human myeloma cell lines and normal bone marrow colony forming cells to a recombinant diphtheria toxin-interleukin 6 fusion protein.
    Chadwick DE; Jean LF; Jamal N; Messner HA; Murphy JR; Minden MD
    Br J Haematol; 1993 Sep; 85(1):25-36. PubMed ID: 8251407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The synergistic influence of human interferon-gamma and interferon-alpha on suppression of hematopoietic progenitor cells is additive with the enhanced sensitivity of these cells to inhibition by interferons at low oxygen tension in vitro.
    Broxmeyer HE; Cooper S; Rubin BY; Taylor MW
    J Immunol; 1985 Oct; 135(4):2502-6. PubMed ID: 3928752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha-2a-interferon/melphalan/prednisone versus melphalan/prednisone in previously untreated patients with multiple myeloma.
    Montuoro A; De Rosa L; De Blasio A; Pacilli L; Petti N; De Laurenzi A
    Br J Haematol; 1990 Nov; 76(3):365-8. PubMed ID: 2261347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A serum-free culture method for myeloma progenitors in vitro: proliferative and immunophenotypic characteristics.
    Rhodes EG; Olive C; Flynn MP
    Exp Hematol; 1990 Feb; 18(2):79-83. PubMed ID: 2406157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of alpha interferon on human long-term bone marrow culture.
    Galvani DW; Cawley JC
    Leuk Res; 1990; 14(6):525-31. PubMed ID: 2374437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of normal human erythropoiesis by human recombinant DNA-produced alpha-2-interferon in vitro.
    Mamus SW; Oken MM; Zanjani ED
    Exp Hematol; 1986 Dec; 14(11):1015-22. PubMed ID: 3780887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary bioassay of human myeloma stem cells.
    Hamburger A; Salmon SE
    J Clin Invest; 1977 Oct; 60(4):846-54. PubMed ID: 302265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha-2-interferon/melphalan/prednisone in previously untreated patients with multiple myeloma: a phase I-II trial.
    Cooper MR; Fefer A; Thompson J; Case DC; Kempf R; Sacher R; Neefe J; Bickers J; Scarffe JH; Spiegel R
    Cancer Treat Rep; 1986 Apr; 70(4):473-6. PubMed ID: 3698041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retinoic acid inhibits the growth of human myeloma cells in vitro.
    Palumbo A; Battaglio S; Napoli P; Bruno B; Omedè P; Boccadoro M; Pileri A
    Br J Haematol; 1995 Mar; 89(3):555-60. PubMed ID: 7734354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.